Skip to main content Skip to navigation
RY703 Rat Anti-Mouse Folate Receptor β (FRβ)

BD OptiBuild™ RY703 Rat Anti-Mouse Folate Receptor β (FRβ)

Clone 10/FR-β (also known as 10/FR2; Clone 10/FR2; CL10)

(RUO)
Product Details
Down Arrow Up Arrow


BD OptiBuild™
FR-beta; Folbp2; Folr2; folate binding protein 2; folate receptor beta
Mouse (Tested in Development)
Rat Wistar IgG2a, κ
Folate Receptor β-transfected RBL2H3 Cells
Flow cytometry (Qualified)
0.2 mg/ml
14276
Aqueous buffered solution containing ≤0.09% sodium azide.
RUO


Preparation And Storage

Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated to the dye under optimum conditions that minimize unconjugated dye and antibody.

Recommended Assay Procedures

BD® CompBeads can be used as surrogates to assess fluorescence spillover (compensation). When fluorochrome conjugated antibodies are bound to BD® CompBeads, they have spectral properties very similar to cells. However, for some fluorochromes there can be small differences in spectral emissions compared to cells, resulting in spillover values that differ when compared to biological controls. It is strongly recommended that when using a reagent for the first time, users compare the spillover on cells and BD® CompBeads to ensure that BD® CompBeads are appropriate for your specific cellular application.

Product Notices

  1. Please refer to www.bdbiosciences.com/us/s/resources for technical protocols.
  2. Please refer to http://regdocs.bd.com to access safety data sheets (SDS).
  3. For U.S. patents that may apply, see bd.com/patents.
  4. Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.
  5. Since applications vary, each investigator should titrate the reagent to obtain optimal results.
  6. The production process underwent stringent testing and validation to assure that it generates a high-quality conjugate with consistent performance and specific binding activity. However, verification testing has not been performed on all conjugate lots.
  7. When using high concentrations of antibody, background binding of this dye to erythroid fragments produced by ammonium chloride-based lysis, such as with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899), has been observed when the antibody conjugate was present during the lysis procedure. This may cause nonspecific staining of target cells, such as leukocytes, which have bound the resulting erythroid fragments. This background can be mitigated by any of the following: titrating the antibody conjugate to a lower concentration, fixing samples with formaldehyde, or removing erythrocytes before staining (eg, gradient centrifugation or pre-lysis with wash). This background has not been observed when cells were lysed with BD FACS™ Lysing Solution (Cat. No. 349202) after staining.
  8. For fluorochrome spectra and suitable instrument settings, please refer to our Multicolor Flow Cytometry web page at www.bdbiosciences.com/colors.
  9. An isotype control should be used at the same concentration as the antibody of interest.
  10. Cy is a trademark of Global Life Sciences Solutions Germany GmbH or an affiliate doing business as Cytiva.
  11. Please observe the following precautions: We recommend that special precautions be taken (such as wrapping vials, tubes, or racks in aluminum foil) to protect exposure of conjugated reagents, including cells stained with those reagents, to any room illumination. Absorption of visible light can significantly affect the emission spectra and quantum yield of tandem fluorochrome conjugates.
  12. Tandem fluorochromes contain both an energy donor and an energy acceptor. Although every effort is made to minimize the lot-to-lot variation in the efficiency of the fluorochrome energy transfer, differences in the residual emission from the donor may be observed. Additionally, multi-laser cytometers may directly excite both the donor and acceptor fluorochromes. Therefore, we recommend for every tandem conjugate, a matched individual single-stain control be acquired for generating a compensation or spectral unmixing matrix.
771861 Rev. 1
Antibody Details
Down Arrow Up Arrow
10/FR-β

The 10/FR-β monoclonal antibody (aka, Clone 10/FR2 or CL10) specifically recognizes mouse Folate Receptor beta (Folate Receptor β or FRβ), a member of the folate receptor family. This cell surface receptor is a glycosylphosphatidylinositol (GPI)-linked membrane protein that is encoded by Folr2 which belongs to the folate-binding receptor family. The Folate Receptor β (FRβ) binds to folate and folic acid derivatives and transports them into cells that are essential for methionine and DNA synthesis which support cell growth and proliferation. Folate Receptor β (FRβ) is expressed on placental cells and on monocytes as well as macrophages found in normal and diseased tissues, eg, tumor-associated macrophages (TAMs) in tumors. Soluble forms of Folate Receptor β (FRβ) have also been described which can be found in various body fluids.

771861 Rev. 1
Format Details
Down Arrow Up Arrow
RY703
The BD Horizon RealYellow™ 703 (RY703) Dye is part of the BD® family of yellow-green dyes. It is a tandem fluorochrome with an excitation maximum (Ex Max) at 557-nm and an emission maximum (Em Max) at 703-nm as measured using an antibody-dye conjugate. Driven by BD® innovation, RY703 can be used on both spectral and conventional cytometers and is designed to be excited by the Yellow-Green laser (561-nm) with minimal excitation by the 488-nm Blue laser. For conventional instruments equipped with a Yellow-Green laser (561-nm), RY703 can be used as an alternative to PE-Cy5.5 and we recommend using an optical filter centered near 700-nm (eg, a 695/40-nm bandpass filter).
altImg
RY703
Yellow-Green 561 nm
557 nm
703 nm
771861 Rev.1
Citations & References
Down Arrow Up Arrow
View product citations for antibody "771861" on CiteAb

Development References (5)

  1. Nagai T, Tanaka M, Tsuneyoshi Y, et al. Targeting tumor-associated macrophages in an experimental glioma model with a recombinant immunotoxin to folate receptor beta.. Cancer Immunol Immunother. 2009; 58(10):1577-86. (Immunogen: Flow cytometry). View Reference
  2. Rodriguez-Garcia A, Lynn RC, Poussin M, et al. CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive immunotherapy.. Nat Commun. 2021; 12(1):877. (Clone-specific: Flow cytometry). View Reference
  3. Roy AG, Robinson JM, Sharma P, et al. Folate Receptor Beta as a Direct and Indirect Target for Antibody-Based Cancer Immunotherapy.. Int J Mol Sci. 2021; 22(11):5572. (Clone-specific: Flow cytometry). View Reference
  4. Tie Y, Zheng H, He Z, et al. Targeting folate receptor β positive tumor-associated macrophages in lung cancer with a folate-modified liposomal complex.. Signal Transduct Target Ther. 2020; 5(1):6. (Clone-specific: Flow cytometry). View Reference
  5. Utz SG, See P, Mildenberger W, et al. Early Fate Defines Microglia and Non-parenchymal Brain Macrophage Development.. Cell. 2020; 181(3):557-573.e18. (Clone-specific: Flow cytometry). View Reference
View All (5) View Less
771861 Rev. 1

 

Please refer to Support Documents for Quality Certificates


Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described


Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims.  Comparisons are not made against non-BD technologies, unless otherwise noted.

For Research Use Only. Not for use in diagnostic or therapeutic procedures.